Market Overview:
The global semi-automatic hemostasis analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for semi-automatic hemostasis analyzers for coagulation testing, anticoagulation testing, and fibrinolytic testing. In addition, the growing prevalence of diseases such as cancer and heart disease is also contributing to the growth of this market. The global semi-automatic hemostasis analyzer market can be segmented on the basis of type into optical semi-automatic hemostasis analyzers, magnetic semi-automatic hemostasis analyzers, and others. The optical segment is expected to account for a major share of the global market in 2018 owing to its high accuracy and precision levels as compared to other types of semiautomatic hemostatis analyzers. On the basis of application, the global semiautomatic hemostatis analzyer market can be divided into coagulation testing, anticoagulation testing, fibrinolytictesting,, and others segments.
Product Definition:
A semi-automatic hemostasis analyzer is a machine used to measure the time it takes for blood to clot. The importance of semi-automatic hemostasis analyzers is that they can help doctors diagnose and treat health conditions related to abnormal blood clotting.
Optical Semi-automatic Hemostasis Analyzer:
The optical semi-automatic hemostasis analyzer is a device used to measure the parameters of platelets and coagulation. It also provides results in few seconds which are helpful for patients who have difficulty in bleeding control. This device has gained popularity due to its accuracy, portability, and user-friendliness features.
Magnetic Semi-automatic Hemostasis Analyzer:
Magnetic semi-automatic hemostasis analyzer is a medical device used for the measurement of platelet count in blood samples. It also provides results pertaining to other parameters such as mean platelet volume, percentiles, and standard deviation along with the overall count and range. The market for magnetic semi-automatic hemostasis analyzer is expected to witness growth over the forecast period owing to increasing prevalence of lifestyle diseases coupled with rising geriatric population base across the globe.
Application Insights:
Based on the application, the market is segmented into coagulation testing, anticoagulation testing, fibrinolytic testing and others. The coagulation tests dominated the overall market in terms of revenue in 2017. It is estimated to continue its dominance over the forecast period owing to an increase in demand for blood samples from trauma patients for cross-matching purposes across hospitals and healthcare facilities. This has resulted in a rise in demand for semi-automatic hemostasis analyzers that perform coagulation tests.
The anticoagulant tests are estimated to witness lucrative growth during the forecast period due to an increase in patient suffering from internal bleeding caused by inadequate clotting of blood cells due to low levels of antithrombin (ATIII) or protein C resistance associated with high risk factors including smoking, obesity and diabetes mellitus type 2.
Regional Analysis:
North America dominated the global semi-automatic hemostasis analyzer market in 2017. This can be attributed to favorable reimbursement policies, increasing R&D investments by major players and rising adoption of advanced technologies in clinical diagnosis. In addition, high incidence of cardiovascular diseases and cancer is also expected to drive the regional demand for SAHAs over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing healthcare expenditure by governments as well as private sectors across various countries such as China, India and Japan. Growing awareness about early diagnosis among people will further propel growth during the forecast period.
Major companies operating in this sector are Siemens Healthcare GmbH & Co., Koninklijke Philips N.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily owing to the benefits offered by these surgeries over traditional open surgery procedures, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Semi-automatic hemostasis analyzers are ideally suited for use in minimally invasive surgical procedures as they offer quick and accurate results without the need for manual intervention or skilled personnel.
- Growing prevalence of cancer: According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for 8 million deaths in 2012 alone. The incidence of cancer is rising rapidly due to factors such as aging population, changing lifestyles (smoking, alcohol consumption), and environmental pollution. This has led to an increased demand for effective diagnostic tools that can help in early detection and treatment of cancers. Semi-automatic hemostasis analyzers play an important role in this regard by providing fast and accurate results that can help physicians make informed decisions about patient treatment plans quickly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Semi-automatic Hemostasis Analyzer Market Research Report
By Type
Optical Semi-automatic Hemostasis Analyzer, Magnetic Semi-automatic Hemostasis Analyzer, Others
By Application
Coagulation Testing, Anticoagulation Testing, Fibrinolytic Testing, Others
By Companies
Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Stago Group (HemoSonics), International Technidyne Corporation (ITC)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Semi-automatic Hemostasis Analyzer Market Report Segments:
The global Semi-automatic Hemostasis Analyzer market is segmented on the basis of:
Types
Optical Semi-automatic Hemostasis Analyzer, Magnetic Semi-automatic Hemostasis Analyzer, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coagulation Testing, Anticoagulation Testing, Fibrinolytic Testing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stago Group (HemoSonics)
- Grifols
- Haemonetics
- Roche Diagnostics
- Abbott (Alere)
- Sysmex Corporation
- Nihon Kohden
- Thermo Fisher Scientific
- Siemens
- Helena Laboratories
- Stago Group (HemoSonics)
- International Technidyne Corporation (ITC)
Highlights of The Semi-automatic Hemostasis Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Optical Semi-automatic Hemostasis Analyzer
- Magnetic Semi-automatic Hemostasis Analyzer
- Others
- By Application:
- Coagulation Testing
- Anticoagulation Testing
- Fibrinolytic Testing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Semi-automatic Hemostasis Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A semi-automatic hemostasis analyzer is a medical device that measures the amount of blood loss from an injury and determines the need for further treatment.
Some of the major players in the semi-automatic hemostasis analyzer market are Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Stago Group (HemoSonics), International Technidyne Corporation (ITC).
The semi-automatic hemostasis analyzer market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Semi-automatic Hemostasis Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Semi-automatic Hemostasis Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Semi-automatic Hemostasis Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Semi-automatic Hemostasis Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Semi-automatic Hemostasis Analyzer Market Size & Forecast, 2020-2028
4.5.1 Semi-automatic Hemostasis Analyzer Market Size and Y-o-Y Growth
4.5.2 Semi-automatic Hemostasis Analyzer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Optical Semi-automatic Hemostasis Analyzer
5.2.2 Magnetic Semi-automatic Hemostasis Analyzer
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coagulation Testing
6.2.2 Anticoagulation Testing
6.2.3 Fibrinolytic Testing
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Semi-automatic Hemostasis Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Semi-automatic Hemostasis Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Optical Semi-automatic Hemostasis Analyzer
9.6.2 Magnetic Semi-automatic Hemostasis Analyzer
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coagulation Testing
9.10.2 Anticoagulation Testing
9.10.3 Fibrinolytic Testing
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Optical Semi-automatic Hemostasis Analyzer
10.6.2 Magnetic Semi-automatic Hemostasis Analyzer
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coagulation Testing
10.10.2 Anticoagulation Testing
10.10.3 Fibrinolytic Testing
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Optical Semi-automatic Hemostasis Analyzer
11.6.2 Magnetic Semi-automatic Hemostasis Analyzer
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coagulation Testing
11.10.2 Anticoagulation Testing
11.10.3 Fibrinolytic Testing
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Optical Semi-automatic Hemostasis Analyzer
12.6.2 Magnetic Semi-automatic Hemostasis Analyzer
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coagulation Testing
12.10.2 Anticoagulation Testing
12.10.3 Fibrinolytic Testing
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Optical Semi-automatic Hemostasis Analyzer
13.6.2 Magnetic Semi-automatic Hemostasis Analyzer
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coagulation Testing
13.10.2 Anticoagulation Testing
13.10.3 Fibrinolytic Testing
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Semi-automatic Hemostasis Analyzer Market: Competitive Dashboard
14.2 Global Semi-automatic Hemostasis Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stago Group (HemoSonics)
14.3.2 Grifols
14.3.3 Haemonetics
14.3.4 Roche Diagnostics
14.3.5 Abbott (Alere)
14.3.6 Sysmex Corporation
14.3.7 Nihon Kohden
14.3.8 Thermo Fisher Scientific
14.3.9 Siemens
14.3.10 Helena Laboratories
14.3.11 Stago Group (HemoSonics)
14.3.12 International Technidyne Corporation (ITC)
